Stephanie J. Culler

I'm super excited today because I have a special guest.

Her name is Stephanie Culler.

Stephanie Culler is the co-op founder and CEO of Personee.

Biosciences, where she is pioneering microbiome-based medicines to transform human health.

She is the lead author of the My Baby Biome Study, the largest US study, to profile the infant gut microbiome.

See, my guest today is a microbiome researcher.

That's Stephanie Culler.

Now, she and her team have been conducting one of the largest infant studies in the U.S. right now.

They're actually mapping the guts of babies and following them for seven years.

So we're just going to jump right into it.

I'm going to shut up.

Let's get into it with Stephanie Culler.

Stephanie Culler, welcome to the show.

And why this is really important is that by age two, We saw that majority of these babies with either low amounts or none of these key bacteria by age two, they were three to four times more at risk for developing atopic dermatitis, food allergies, and asthma.

Today, we are speaking with Dr. Stephanie Culler, co-founder and CEO of Persephone Biosciences.

We'll talk about the baby microbiome and how exactly to improve it, along with so much more on this week's episode of My Allergist Dad.

Skin rash or a patch of eyes.

Hey, Dad.

Hey, Drew.

I'm very excited, as I know you are, to introduce our guest for this week's episode, Dr. Stephanie Culler, the co-founder and CEO of Persephone Biosciences.

who led the My Baby Biome Study, the largest U.S. infant gut microbiome study ever published, finding 9 in 10 babies are missing key beneficial microbes tied to eczema, food allergies, and asthma.